Global  

AstraZeneca, Johnson & Johnson to resume COVID-19 vaccine trials

CBS News Saturday, 24 October 2020
On Friday, both AstraZeneca and Johnson & Johnson announced their coronavirus vaccine trials are set to resume in the U.S. after hitting pause when volunteers became sick.
0
shares
ShareTweetSavePostSend
 

💡 One News Page Knowledge: Other News Mentions

AstraZeneca British-Swedish pharmaceutical company

AstraZeneca partner sticks with two full dose regimen in Covid trials in India

The British drugmaker has said its Covid-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose, but some scientists have..
IndiaTimes

Serum says AstraZeneca's Covid-19 vaccine safe, no co-relation with side-effects

Serum Institute of India, the world's largest vaccine manufacturer, on Tuesday denied allegations that a Covid-19 trial volunteer suffered serious side effects..
IndiaTimes

India looking to be self-reliant in development, production of vaccine against Covid-19

While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass production of..
IndiaTimes
COVID-19 vaccine will be distributed initially in India: CEO Serum Institute of India [Video]

COVID-19 vaccine will be distributed initially in India: CEO Serum Institute of India

COVID-19 vaccine will be distributed initially in India, informed Chief executive officer (CEO) of Serum Institute of India, Adar Poonawalla on November 28. He said, "Vaccine will be distributed initially in India, then we will look at the COVAX countries which are mainly in Africa. The UK and European markets are being taken care of by AstraZeneca and Oxford. Our priority is India and COVAX countries." Earlier in the day, Prime Minister Narendra Modi visited Serum Institute of India in Pune, Maharashtra to and reviewed COVID-19 vaccine development.

Credit: ANI    Duration: 01:25Published

Johnson & Johnson Johnson & Johnson U.S. multinational medical manufacturer

Missouri Supreme Court blocks J&J’s damages appeal [Video]

Missouri Supreme Court blocks J&J’s damages appeal

Missouri's highest court on Tuesday refused to consider Johnson & Johnson's appeal of a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in its baby powder and other talc products. Bryan Wood reports.

Credit: Reuters Studio    Duration: 01:08Published
J&J, AstraZeneca resuming trials of vaccines [Video]

J&J, AstraZeneca resuming trials of vaccines

AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on Friday. Fred Katayama reports.

Credit: Reuters Studio    Duration: 01:08Published
Global COVID-19 cases rise by a one-day record [Video]

Global COVID-19 cases rise by a one-day record

Global coronavirus cases rose by more than 400,000 for the first time late on Friday, a record one-day increase as much of Europe enacts new restrictions to curb the outbreak. Freddie Joyner has more.

Credit: Reuters - Politics    Duration: 01:18Published
Johnson & Johnson Halts COVID-19 Vaccine Trial Due to Unexplained Illness [Video]

Johnson & Johnson Halts COVID-19 Vaccine Trial Due to Unexplained Illness

Johnson & Johnson has paused the advanced clinical trial of its experimental COVID-19 vaccine after one of their 60,000 participants became ill.

Credit: Cover Video STUDIO    Duration: 01:19Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Mnuchin and Pelosi to resume COVID aid talks

Speaker of the House Nancy Pelosi and Treasury Secretary Steven Mnuchin are set to resume their talks about COVID relief. Mnuchin spoke to reporters before..
USATODAY.com
COVID-19: Govt never spoke about vaccinating the entire country, says Health Ministry [Video]

COVID-19: Govt never spoke about vaccinating the entire country, says Health Ministry

On being asked about how much time it will take to vaccinate the entire country, Health and Family Welfare Ministry Secretary Rajesh Bhushan clarified that Central Government has never spoken about vaccinating the entire country. "It's important that we discuss such scientific issues, based on factual information only," he said.

Credit: ANI    Duration: 00:57Published
World AIDS Day: resources redirected towards fighting Covid-19 [Video]

World AIDS Day: resources redirected towards fighting Covid-19

Credit: FRANCE 24 English    Duration: 03:19Published

Aston Villa v Newcastle postponed because of Covid outbreak at Magpies' training ground

Newcastle's game at Aston Villa on Friday is postponed following a significant increase in Covid-19 cases at the Magpies' training ground.
BBC News

You Might Like


Related videos from verified sources

Oxford Astra Zeneca's vaccine error | What happens to India trials? | Oneindia News [Video]

Oxford Astra Zeneca's vaccine error | What happens to India trials? | Oneindia News

Even as Oxford and Astra Zeneca said that their Covid-19 vaccine had a 90% efficacy, their claims it turned out were based on an accident. Oxford Astrazeneca said that when volunteers were administered..

Credit: Oneindia     Duration: 01:25Published
Questions over AstraZeneca's COVID-19 vaccine data [Video]

Questions over AstraZeneca's COVID-19 vaccine data

British drugmaker AstraZeneca is working with regulators to investigate a lower dosage of its vaccine that performed better than a full dosage, a spokesman for the company said on Thursday, after its..

Credit: Reuters - Politics     Duration: 01:29Published
Dosing Mix-up Raises Questions About New COVID Vaccine [Video]

Dosing Mix-up Raises Questions About New COVID Vaccine

A manufacturing error is raising concerns about a promising COVID-19 vaccine being developed. The vaccine was developed by pharmaceutical company AstraZeneca and the University of Oxford. Less than a..

Credit: Wochit News     Duration: 00:39Published